Category: Angeion Corp.
Wright Medical Group says it's planning a private placement for $200 million worth of senior notes.
Wright Medical (NSDQ:WMGI) said it's planning a private placement for $200 million worth of senior notes due 2017.
Zimmer plans cuts and outsourcing at its Warsaw, Ind., headquarters partially to offset the impending burden of a 2.3% medical device tax.
Zimmer Holdings (NYSE:ZMH) announced layoffs at its Warsaw, Ind., headquarters, pointing to the expected burden of the medical device tax as partly responsible for some of the losses.
The orthopedics device maker plans to offset the entire burden posed by the impending 2.3% device levy in 2013 through cost-cutting efforts, part of which include layoffs.
Angeion makes up for sagging European sales by focusing on group purchasing organizations and service revenues in Q1; also, Natus Medical's earnings plunge; Mindray posts big boosts to top, bottom lines; iCad narrows quarterly losses; MiMedx sales soar in 2011; InSite's sales slide, losses widen; Exactech's bottom line shrinks; Viking boosts sales, widens losses; MedPro cuts losses; and Alphatec dives deeper into the red.
Angeion Corp. (NSDQ:ANGN) narrowed its 1st-quarter losses despite flat sales for the 3 months ended Jan. 31.
Although dragged down by a tough European climate, focusing on group purchasing organization and service revenues kept the company's sales from sliding, the cardiorespiratory diagnostic systems maker said.
Campbell Rogers, the chief scientific officer for Johnson & Johnson's Cordis Corp., leaves after nearly 6 years to join HeartFlow as its chief medical officer.
Campbell Rogers is leaving his post as chief scientific officer for Johnson & Johnson's (NYSE:JNJ) Cordis Corp. – a role created for him in July 2006 – to take the chief medical officer job at startup HeartFlow.
AngioDynamics CEO Joseph DeVivo tells MassDevice that the $372 million deal to acquire Navilyst Medical is a chance to set the combined companies on a sound foundation; plus, CEO pay: $1.4M for no growth?; Greenway Medical readies IPO; Exactech releases Q4 prelims, 2012 guidance; and analysts' ups and downs.
Updated February 1, 2012 at 5:30 p.m.
The $372 million buyout of Navilyst Medical by AngioDynamics (NSDQ:ANGO) is a reset button that will reinforce the combined operation for the future, AngioDynamics CEO Joe DeVivo told MassDevice this afternoon.
Orthopedics bellwether Biomet's 2nd-quarter preliminary sales numbers are up 4%, sending other ortho stocks up on Wall Street; also, quarterly results for Analogic; Angeion; Cantel Medical; Cyberonics; Hamilton Thorne; LED Medical; Mauna Kea Technologies; Mazor Robotics; Optos; Rectractable Technologies; Sectra; SeraCare; Sirona Dental; Solos Endoscopy; Synergetics; Synovis; and World Heart Corp.
Shares of orthopedic device makers are up this morning after bellwether Biomet Inc. reported preliminary sales numbers indicating 3.8% growth for its fiscal second quarter.